Abstract:Background and Aim Epigenetic modification is an important part of the pathogenesis of inflammatory bowel disease (IBD). Some studies proved that p62 was involved in inflammatory response and upregulated in IBD patients, and histone modification plays an important role in regulating p62 expression. SETD8, a histone H4K20 methyltransferase, has been reported downregulated in some inflammatory diseases. Here, we investigated the role of SETD8 in the development of IBD and its underlying mechanisms. Methods An inflammatory cell model was established to elucidate whether SETD8 involved in inflammatory response in macrophages. Three percent dextran sodium sulfate-induced colitis murine model injection with SETD8 inhibitor was used in our study to investigate whether SETD8 inhibition can affect the progress of IBD. The expression of SETD8 and p62 was measured by qRT-PCR and western blot. The mRNA level of inflammatory cytokines was analyzed by qRT-PCR. In addition, chromatin immunoprecipitation-PCR was performed to identify the mechanism by which SETD8 regulates p62. Results SETD8 expression obviously decreased in vitro, in vivo models and in IBD patients. In lipopolysaccharide-activated RAW264.7 cells, knockdown of SETD8 significantly increased the mRNA expression of inducible nitric oxide synthase, cyclooxygenase-2, TNF-alpha, IL-6, IL-1 beta, and MCP-1. Based on the dataset, we verified that p62 was a target gene of SETD8 and chromatin immunoprecipitation-PCR assay identified that silence of SETD8 distinctly decreases the H4K20me1 enrichment in the promoter of p62. Moreover, silencing of p62 partly reverses the SETD8 inhibition-mediated pro-inflammatory effect in vitro. Finally, SETD8 pharmacological inhibitor (UNC0379) aggravated the disease progression in dextran sodium sulfate-induced murine colitis. Conclusion Our findings elucidate an epigenetic mechanism by which SETD8 regulates the p62 expression and restrains the inflammatory response in colitis. Our result suggests that targeting SETD8 may be a promising therapy for IBD.

Methyltransferase Setd2 Prevents T Cell-Mediated Autoimmune Diseases Via Phospholipid Remodeling

Ash1l and lnc-Smad3 coordinate Smad3 locus accessibility to modulate iTreg polarization and T cell autoimmunity

Methyltransferase SETD2-Mediated Methylation of STAT1 is Critical for Interferon Antiviral Activity.

Macrophage/microglial Ezh2 facilitates autoimmune inflammation through inhibition of Socs3.

Setd2 Regulates Quiescence and Differentiation of Adult Hematopoietic Stem Cells by Restricting RNA Polymerase II Elongation.

KMT2D Histone Methyltransferase Modulates Chromatin Accessibility During Regulatory T Cell Development (LYM6P.714)

Genetic ablation of steroid receptor coactivator-3 promotes PPAR-β-mediated alternative activation of microglia in experimental autoimmune encephalomyelitis

MBD2 Regulates TH17 Differentiation and Experimental Autoimmune Encephalomyelitis by Controlling the Homeostasis of T-bet/Hlx Axis.

The histone methyltransferase SETD2 modulates oxidative stress to attenuate experimental colitis

Role of Tet2 in Regulating Adaptive and Innate Immunity

Metabolic control of TH17 and induced Treg cell balance by an epigenetic mechanism

The effects of post-translational modifications on Th17/Treg cell differentiation

SETD8 Involved in the Progression of Inflammatory Bowel Disease Via Epigenetically Regulating P62 Expression.

M 6 A Mrna Modification Potentiates Th17 Functions to Inflame Autoimmunity

Phosphatase PP2A is Essential for T H 17 Differentiation

Hydrogen Sulfide Promotes Tet1- and Tet2-Mediated Foxp3 Demethylation to Drive Regulatory T Cell Differentiation and Maintain Immune Homeostasis.

Increased EZH2 function in regulatory T cells promotes their capacity to suppress autoimmunity by driving effector differentiation prior to activation

Sphingolipid biosynthesis is essential for metabolic rewiring during T H 17 cell differentiation

SETD8 involved in the progression of IBD via epigenetically regulating p62 expression

Setd2 determines distinct properties of intestinal ILC3 subsets to regulate intestinal immunity

Sirtuin2 suppresses the polarization of regulatory T cells toward T helper 17 cells through repressing the expression of signal transducer and activator of transcription 3 in a mouse colitis model